Tustin, CA – Integrium Executives will be in Boston for the 2017 Microbiome Drug Development Summit on June 27-29. Intrigued by the summits' information-filled approach, Integrium Executives are looking forward to gaining access to microbiome clinical information to broaden the future in this rapidly changing therapeutic area.
Integrium, LLC to Attend 2017 Microbiome Drug Development Summit in Boston, MA
Integrium, LLC to Attend RESI San Diego 2017
By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending RESI San Diego 2017 on June 19, 2017. RESI allows life science companies to connect with investors that come from backgrounds related to Virtual Pharma, Angels, Venture Philanthropy, Patient Groups, Corporate Development, and more.
Integrium, LLC to Attend 2017 BIO International Convention in San Diego, CA
By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending the 2017 BIO International Convention located in San Diego, CA on June 19-22. Integrium is looking forward to joining other industry leaders and pharmaceutical companies to fulfill networking goals and potential partnerships.
Integrium, LLC to Attend 2017 Marcum MicroCap Conference
By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending the 2017 Marcum MicroCap Conference on June 15-16 at the Grand Hyatt New York. Integrium helps micro-cap and small-cap biotechs attain clinical data so they can raise their next round of capital.
Integrium, LLC to Attend Alliance for Regenerative Medicine 5th Annual Cell & Gene Investor Day in Boston!
By: Emily MacHale
Tustin, CA – Executives of the Integrium team will be in Boston during the Alliance for Regenerative Medicine 5th Annual Cell & Gene Investor Day on April 27th, 2017. On this one day filled with opportunity for investors to collaborate with advanced therapeutic biotechs, Integrium seeks to meet and gain insight on how they can be of help to numerous life science experts.
Get a second opinion for your RFP or budget
Should my biotech get a second opinion?
Have you had the same family doctor, the same dentist, and the same eye doctor…. for your entire life?
What if someone told you that there are thousands upon thousands of other doctors out there that could give you more feedback, alternative options or even lower pricing?
As a Clinical CRO partner to many, Integrium wants biotechnology Executives and Managers to choose Integrium as THE second opinion for your RFP and/or budget.
Integrium, LLC Executives to Attend RESI on MaRS 2017!
By: Emily MacHale
Tustin, CA – Integrium, LLC Executives will attend RESI on MaRS 2017 in Toronto, Canada on April 4, 2017. Hosted each year, RESI is notorious for providing meetings for hungry fundraisers and allowing them to connect with eager life science investors.
Integrium, LLC Executives to Attend 2017 MassBio Annual Meeting!
By: Emily MacHale
Tustin, CA – Integrium, LLC Executives are attending the 2017 MassBio Annual Meeting in Boston, MA on March 30 – 31, 2017. Each year, the Integrium team is happy to be a part of the fast-paced program the Massachusetts Life Sciences industry offers.
Integrium, LLC Executives to Attend DCAT Week 2017!
By: Emily MacHale
Tustin, CA – Members of the Integrium Executive Management Team will be attending DCAT Week 2017 in New York City on March 20th through 23rd. DCAT Week 2017 is different from previous years because of the improvements and changes to many of the meeting spaces, networking events, venues, and more.
Integrium, LLC Launches Newly Revamped Company Website
Tustin, CA – Integrium, LLC, a full-service Clinical Proof of Concept (PoC) Firm, announced today the launch of its newly revamped company website. This updated website offers quick and easy navigation throughout the company’s portals of clinical trial therapeutic experience and key CRO services with detailed information.